AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 261 min read$ANL

Ye Xiaofeng sold $165K of ANL

Ye Xiaofeng (CFO) sold 11,667 shares of Adlai Nortye Group Ltd. (ANL) at an average of $14.11 ($13.98–$14.25, $0.16M total) across 2 trades over 2026-08-24 to 2026-08-26.

Original reporting
SEC EDGAR · Ye Xiaofeng
Published Aug 26, 2026, 8:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 8:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ANL
Neutral
high confidence
Mentioned
$ANL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANLNeutralLow
01

Why it matters

The disclosed sale represents a modest reduction in insider stake, with minimal effect on market perception.

02

Market read

Limited relevance; primarily of interest to shareholders monitoring insider activity.

03

What to watch

Potential upcoming corporate actions or earnings that prompted the insider to adjust holdings.

Relevance 4/10Novelty 4/10Timing: filed 2026-08-26

Background

Form 4 filings disclose insider trades and are required by the SEC. Small insider sales are common and usually not market‑moving.

Company-level read

Ticker impact

$ANLNeutralHigh confidence
Context

CFO Ye Xiaofeng sold 11,667 shares for $164,635 in an open‑market transaction filed on 2026‑08‑26.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale size is small relative to total shares outstanding and typical insider trading volumes.

Market effects

Sector

None; transaction is company‑specific.

Regional

None; limited to ANL shareholders.

Global

None

Counterpoint

What could challenge this read

The sale could be interpreted as insider confidence if viewed as routine portfolio rebalancing.

Key entities

  • Company
    Adlai Nortye Group Ltd.

    Issuer of the stock traded under ticker ANL.

  • Individual
    Ye Xiaofeng

    Chief Financial Officer of ANL who executed the sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ANL insider trading history →

Related articles

AUG 14
$ANLMedAI 8/10

Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Adlai Nortye Ltd. (NASDAQ: ANL) reported unaudited first-half 2026 results and pipeline updates. It said enrollment is ongoing for Phase I AN9025 in QD and QW arms, and it received Australia HREC approval for Phase I AN4035. Cash and short-term investments were $231.9M at June 30, 2026. Net loss fell to $5.3M; revenue rose to $13.1M.

finanznachrichten.de6 min
JUL 7
$LUCYMedAI 8/10

Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update

Biotech gainers: Innovative Eyewear (LUCY) rose 63% after preliminary Q2 2026 net sales of ~$0.99M (+71% YoY) and new retail orders; Seer (SEER) jumped 35% on an unsolicited $2.45/share cash takeover proposal plus contingent value rights; Orthofix (OFIX) and Enovis (ENOV) gained 16%/15% after CMS withdrew reimbursement changes for non-invasive bone growth stimulators.

rttnews.com6 min